Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what he hopes to see in 2027.
|Articles|October 26, 2012
Disease Progression Evident in Progressive Glaucomatous Optic Neuropathy
“Structural remodeling†is how Andrew B. Mick, OD, FAAO, described the visual signs of glaucoma progression at the Glaucoma SIG symposium, Identifying Glaucoma Progression: A Clinical Discussion, during the 2012 American Academy of Optometry meeting.
Advertisement
Advertisement
Related to this article
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026.
Christina M. Danley, OD, FOVDR, explores the many nuances that require consideration when answering a common question asked by parents of children with myopia.
Kevin Chan, OD, MS, discusses an AAOpt 2026 symposium on individualized low-dose atropine dosing for myopia and the FDA outlook ahead of the SYD-101 advisory meeting.
Raman Bhakhri, OD, FAAO, alongside Xiao Yu, OD, FAAO, discussed emerging investigational therapies for the disease during their AAOpt 2026 session.
A single Epioxa epi-on cross-linking treatment sustained a 1.9 D Kmax improvement through three years in keratoconus, with no serious adverse events reported.
Jamie Kuzniar, OD, FAAO, FSLS, discusses a case-based AAOpt 2026 session on scleral lens complications, fitting around cross-linking, and advice for new graduates.
IDOC's 2025 benchmarks from 175-plus independent OD practices put median practice net at 31% of revenue as variable costs fell for the first time since tracking began.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
The screen time question: What to ask and when to look deeper
2
AAOpt 2026: Understanding the gene therapy landscape for retinitis pigmentosa
3
AAOpt 2026: Current controversies in macular hole diagnosis, management
4
AAOpt 2026: Jeffrey Walline, OD, PhD, on his conference takeaways
5